Easycess won the first prize in the Industrial Transformation special Competition of China Medical Device Innovation and Entrepreneurship Competition

On September 23, 2022, Guangzhou Easycess Medical Co.,Ltd won the first prize in the Industrial Transformation Special Competition of the 5th China Medical Device Innovation and Entrepreneurship Competition!

In this competition, more than 80 excellent innovative enterprise projects launched a fierce competition, rounds of wonderful speeches not only reflected the innovation achievements of various enterprises, but also for the innovation achievements of domestic medical device products. After the on-site road show and question and answer session, the judges scored strictly on five dimensions: innovation, clinical value and social value, project progress, team and risk assessment. In the end, Easycess 'project "New Trend in Stroke Treatment - Family of Thrombus catheters with one Recirculation" was highly recognized by the judges and finally won the first prize!

Easycess focuses on the development of vascular interventional devices and is committed to making interventional therapy easier with innovative technology. The products in this competition are for the treatment of acute ischemic stroke (AIS), which is characterized by high morbidity, mortality and disability. At present, the main treatment options for AIS include stent thrombectomy, suction thrombectomy, and combined thrombectomy. With the continuous improvement of the new generation of aspiration catheter technology, the higher capacity of blood vessels in place, and the stronger suction capacity, the proportion of FPE has been greatly improved, the patient's prognosis is better, and more patients have less financial burden. Easycess focuses on ADAPT(Direct suction once and again) technology in the field of stroke thrombectomy, and the layout of suction catheter family products, led by Speedpass® innovative products, will bring more benefits to doctors and patients.

Innovation leads development. In the post-growth era, reshaping the spirit of artisans is the only way to survive and develop. Easycess always adheres to the values of "life first, pragmatic and efficient, breakthrough and innovation, honest and trustworthy", based on clinical needs, strives for product excellence, and strives for advanced design concepts and innovative products, with the goal of solving disease problems in a more convenient and cheap way.

In just two years since its establishment, Easycess has achieved great development. Easyport® distal access catheter, Speedpass® thrombus aspiration catheter, Easytork® Neurovascular guide filament and Speedfalte™ intracranial balloon dilatation catheter have been approved by NMPA. Its excellent product performance is widely recognized by experts in the field.

In the future, Easycess will continue to market more innovative products to meet clinical needs. Based on the domestic market at the same time, Easycess layout overseas market, has passed the ISO13485:2016 international system certification, at the same time, the remote access catheter was approved by the FDA listing.

The first time to participate in the domestic competition, for the growth of Easycess is more learning and reference. Thanks to the high recognition of the jury of this competition, we will forge ahead and live up to our time; We will shoulder the mission, innovation and entrepreneurship.